|
MEF2D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.35049782257602E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12000417221248E-11 |
| Normal-vs-Stage2 |
8.30299999865503E-08 |
| Normal-vs-Stage3 |
2.7141999999758E-06 |
| Normal-vs-Stage4 |
1.430020E-02 |
| Stage1-vs-Stage2 |
5.761000E-01 |
| Stage1-vs-Stage3 |
1.005220E-01 |
| Stage1-vs-Stage4 |
9.079000E-01 |
| Stage2-vs-Stage3 |
3.378800E-01 |
| Stage2-vs-Stage4 |
7.524600E-01 |
| Stage3-vs-Stage4 |
4.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.10189660016158E-11 |
| Normal-vs-AfricanAmerican |
2.31709995635043E-09 |
| Normal-vs-Asian |
1.99076999999326E-05 |
| Caucasian-vs-AfricanAmerican |
9.357600E-01 |
| Caucasian-vs-Asian |
4.991400E-01 |
| AfricanAmerican-vs-Asian |
4.126200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.01594338181621E-12 |
| Normal-vs-Female |
2.23269999999332E-06 |
| Male-vs-Female |
1.508430E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.922650E-03 |
| Normal-vs-Extreme_Weight |
3.14548387336799E-12 |
| Normal-vs-Obese |
1.79080000051179E-07 |
| Normal-vs-Extreme_Obese |
2.85210000061653E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.950580E-01 |
| Normal_Weight-vs-Obese |
8.230600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.492200E-02 |
| Extreme_Weight-vs-Obese |
3.676000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.073200E-01 |
| Obese-vs-Extreme_Obese |
1.699680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.558530E-03 |
| Normal-vs-Age(41-60Yrs) |
5.01560015742086E-10 |
| Normal-vs-Age(61-80Yrs) |
2.42460496124863E-11 |
| Normal-vs-Age(81-100Yrs) |
9.03109997896223E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.132000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.015800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.314100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.895200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.201170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.588230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67066360745594E-12 |
| Normal-VS-Type2 PRCC |
3.25040000026533E-07 |
| Normal-VS-KIRP CIMP |
2.505800E-01 |
| Normal-VS-Unclassified PRCC |
2.24500000000072E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.091000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.828900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.699790E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.860400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.213400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.002620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.5527136788005E-15 |
| Normal-vs-N1 |
2.168900E-04 |
| Normal-vs-N2 |
9.066600E-01 |
| N0-vs-N1 |
1.952170E-02 |
| N0-vs-N2 |
1.431170E-01 |
| N1-vs-N2 |
9.966200E-02 |
|
|
